Skip Navigation LinksMedicalDeviceSafetyProgram

Food and drug branch (FDB)

 FDB Home Page


Main Telephone:

(800) 495-3232




Address (Courier Delivery):

California Department of Public Health - Food and Drug Branch

1500 Capitol Ave, MS 7602

Sacramento, CA 95814


Address (Non-Courier Delivery):

California Department of Public Health - Food and Drug Branch

P.O. Box 997435, MS 7602

Sacramento, CA 95899

Medical Device Safety Program

The Medical Device Safety Section's mission is to provide an uncompromising standard of public health protection by assuring that medical devices produced and retailed in California are safe and effective. We accomplish our mission through scientific-based investigations and specific legal authority, uniformity of enforcement, balanced with effective industry and consumer education by employing leading-edge technology. We also endeavor to achieve a partnership with industry and public sector through our commitment to fair business and regulatory practices.

Our vision is to be a globally recognized model for excellence in medical device safety, fostering industry growth and technological innovation, creating a fair and scientific-based regulatory environment that attracts responsible industry to California, and assuring public health protection for all users of California-produced devices.

For any questions, please contact us using the information on the left or email us as the following address:

 News and Updates

Device Recalls

Industry Advisory: New Labeling Law Affecting the Manufacture, Sale, and Distribution of Menstrual Products Effective January 1, 2023 (PDF)

Health Advisory: Cybersecurity FAQs (PDF)

Health Advisory: Decorative Contact Lenses (PDF)

FDA Recall: Jiangsu Well Biotech Co., Ltd. Recalls COVID-19 Ag Rapid Test Devices (PDF)

Extended Expiration Date: MaximBio COVID-19 Antigen Home Test

FDA Alert: Counterfeit At-Home OTC COVID-19 Diagnostic Tests

FDA Safety Communication: FDA Warns Against Use of Renuvion/J-Plasma Device for Certain Aesthetic Procedures

FDA Cybersecurity Notice: Vulnerabilities identified in medical device software components: PTC Axeda agent and Axeda Desktop Server

FDA Safety Communication:  Do Not Use SD Biosensor STANDARD Q COVID-19 Ag Home Tests and Pilot Covid-19 At Home Tests​

FDA Safety Communication: Potential Risk of Strangulation in Children who Use Enteral Feeding Delivery Sets

FDA Safety Communication: Stop Using LuSys Laboratories COVID-19 Tests

Health Advisory: Defective Imported Medical Gloves (PDF)

CDPH News Release-​CDPH Warns Consumers about Risks of Wearing Decorative Contact Lenses

FDA Alert: Stop using Certain N95 Respirators Manufactured by Shanghai Dasheng - Letter to Health Care Providers

FDA Alert :  Stop Using Innova SARS-CoV-2 Antigen Rapid Qualitative Test - FDA Safety Communication

FDA MedWatch-JET 7 Catheters with Xtra Flex Technology by Penumbra: Recall-Due to Increased Risk of Mortality and Serious Injury

FDA Alert: An Increased Risk of a False Positive Result with BD SARS-CoV-2 Reagentsfor the BD Max System Test

Governor Newsom Signs Executive Order on Actions in Response to COVID-19 6.5.20

Executive Order N-68-20 (PDF)

Statement from FDA Commissioner Scott Gottlieb, M.D., on signing of the Agriculture Improvement Act and the agency’s regulation of products containing cannabis and cannabis-derived compounds

Decorative Contact Lenses - Corneal Ulcers

Decorative Contact Lenses - Corneal Edema

Decorative Contact Lenses - Eye Redness

Decorative (Colored) Contact Lenses - Corneal Ulcer

Page Last Updated :